Concentric Capital Strategies’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$696K Buy
4,730
+2,577
+120% +$419K 0.06% 184
2025
Q4
$420K Sell
2,153
-3,311
-61% -$788K 0.02% 232
2025
Q3
$1.54M Sell
5,464
-85,084
-94% -$21.7M 0.07% 212
2025
Q2
$19.8M Buy
90,548
+86,885
+2,372% +$14M 0.88% 14
2025
Q1
$512K Sell
3,663
-16,656
-82% -$2.71M 0.05% 145
2024
Q4
$3.39M Sell
20,319
-26,126
-56% -$4.64M 0.16% 128
2024
Q3
$7.91M Sell
46,445
-8,037
-15% -$1.16M 0.33% 78
2024
Q2
$7.69M Buy
54,482
+10,214
+23% +$1.27M 0.39% 55
2024
Q1
$5.56M Buy
+44,268
New +$5.07M 0.31% 78
2023
Q4
Sell
-14,228
Closed -$1.51M 296
2023
Q3
$1.51M Sell
14,228
-54,262
-79% -$6.28M 0.16% 119
2023
Q2
$8.16M Buy
+68,490
New +$7.08M 1.64% 7
2022
Q4
Sell
-33,773
Closed -$2.06M 191
2022
Q3
$2.06M Buy
+33,773
New +$2.47M 0.73% 51

Other funds holding ORCL

Concentric Capital Strategies's ORCL Position: Q1 2026 in Review

Concentric Capital Strategies increased its Oracle (ORCL) stake by 120% in Q1 2026, buying an estimated $419K and bringing the position to 4,730 shares worth $696K. The position accounts for 0.06% of the portfolio, ranked #184.

Concentric Capital Strategies first reported a position in ORCL in Q3 2022 and has held it in 12 quarters since. The position peaked at $19.8M in Q2 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Concentric Capital Strategies held 4,730 shares of Oracle worth $696K as of Q1 2026.
  • Concentric Capital Strategies bought 2,577 Oracle shares in Q1 2026, an estimated $419K.
  • Oracle made up 0.06% of Concentric Capital Strategies's portfolio in Q1 2026, its #184 holding.
  • Concentric Capital Strategies first reported a position in Oracle in Q3 2022 and has held it in 12 quarters since.
  • Concentric Capital Strategies's Oracle position peaked at $19.8M in Q2 2025.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Concentric Capital Strategies's 13F filing for Q1 2026, filed 15 May 2026.